{"gene":"BCKDHA","run_date":"2026-06-09T22:02:44","timeline":{"discoveries":[{"year":1989,"finding":"The BCKDHA gene encoding the E1α subunit of branched-chain keto acid dehydrogenase was mapped to human chromosome region 19q13.1–q13.2 by in situ hybridization with 3H-labeled cDNA.","method":"Chromosomal in situ hybridization (cytogenetics)","journal":"Cytogenetics and cell genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct in situ hybridization localization experiment, single lab, single method","pmids":["2805821"],"is_preprint":false},{"year":1993,"finding":"The human BCKDHA gene contains 9 exons spanning at least 55 kb; exon 1 is 135 bp with multiple transcription initiation sites at +1, +18, and +22; the promoter lacks a canonical TATA box but contains Sp1, CAAT-like, AP-2, glucocorticoid-responsive element, and cAMP-responsive element sequences. The region for high-level transcription in hepatoma (Hep-G2) cells lies between –320 and –115, with inhibitory elements upstream of –320, while in CHO cells the high-level region extends to –909 to –115, indicating cell-type-specific promoter regulation.","method":"Genomic library cloning, sequencing, deletion constructs with luciferase reporter assay in Hep-G2 and CHO cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct functional promoter dissection with deletion constructs and reporter assay, two cell lines, single lab","pmids":["8463340"],"is_preprint":false},{"year":1998,"finding":"A C-to-T transition in exon 7 of BCKDHA produces a nonsense mutation (R242X) that abolishes branched-chain α-ketoacid dehydrogenase activity, as confirmed in cultured amniocytes with absent enzyme activity from a consanguineous pedigree with MSUD.","method":"PCR amplification and mutation analysis of BCKDHA exon 7 in amniocytes with enzyme activity assay","journal":"Human mutation","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — enzymatic activity correlated with specific mutation, single case/pedigree, single lab","pmids":["10694918"],"is_preprint":false},{"year":2008,"finding":"A large deletion of ~13.8 kb in BCKDHA encompassing exons 2–4 (from intron 1 to intron 4) causes MSUD; the deletion junction contains a short CGGG motif present in both introns, supporting non-homologous recombination as the causative mechanism.","method":"Long-range PCR and sequencing to characterize deletion breakpoints in a MSUD patient","journal":"Journal of inherited metabolic disease","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — direct molecular characterization of deletion breakpoints, mechanistic inference about non-homologous recombination, single case","pmids":["19085071"],"is_preprint":false},{"year":2009,"finding":"The c.117delC-α (p.R40GfsX23) mutation in BCKDHA is a founder mutation responsible for high MSUD incidence among Portuguese Gypsies, as demonstrated by haplotype analysis with four flanking microsatellite markers; the genomic region around this mutation is a mutational hotspot since it was also found recurrently in distinct population groups.","method":"Microsatellite haplotyping and population genetics analysis flanking the BCKDHA gene","journal":"Annals of human genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct haplotype analysis linking mutation to founder effect, replicated in two population groups, single lab","pmids":["19456321"],"is_preprint":false},{"year":2010,"finding":"The intronic mutation c.288+9C>T in BCKDHA creates a cryptic splice site, causing insertion of a 7-bp fragment from intron 2 into the mRNA with a premature stop codon; this aberrant transcript is subject to nonsense-mediated mRNA decay (NMD), as demonstrated by emetine rescue and minigene splicing assays. A low level of normal mRNA is also produced from this allele, correlating with the milder variant MSUD phenotype observed in the patient (compound heterozygous with the severe p.Gly249Ser allele).","method":"Direct mRNA analysis from patient cells, emetine rescue experiment, minigene splicing assay","journal":"Journal of inherited metabolic disease","confidence":"High","confidence_rationale":"Tier 1 / Moderate — minigene reconstitution, patient mRNA analysis, and emetine rescue provide orthogonal mechanistic evidence; single lab","pmids":["20431954"],"is_preprint":false},{"year":2011,"finding":"Two novel missense mutations in BCKDHA — p.L103P (in the helical region) and p.R265P (in the core domain near the cofactor/manganese-binding site) — were identified in a Chinese MSUD patient; structural modeling indicated p.L103P disrupts hydrophobic cores and shortens the helix, while p.R265P affects the cofactor binding site by altering manganese ion coordination.","method":"Sanger sequencing of BCKDHA, protein structural modeling with PyMOL","journal":"Journal of pediatric endocrinology & metabolism : JPEM","confidence":"Low","confidence_rationale":"Tier 4 / Weak — structural inference is computational only (PyMOL modeling), no in vitro functional validation","pmids":["22145486"],"is_preprint":false},{"year":2021,"finding":"BIX01294 (a G9a inhibitor) transcriptionally downregulates BCKDHA expression in EGFR-mutant NSCLC cells through inhibition of KDM3A (a Jumonji histone demethylase) rather than G9a; KDM3A epigenetically regulates BCKDHA expression by binding to the BCKDHA gene promoter. BCKDHA downregulation reduces mitochondrial metabolic function and TCA cycle fueling, leading to decreased cellular energy levels, reduced EGFR protein levels, and apoptosis specifically in EGFR-mutant cells.","method":"BIX01294 treatment, BCKDHA knockdown, chromatin binding assay (KDM3A at BCKDHA promoter), mitochondrial metabolic assays, apoptosis assays in NSCLC cells","journal":"Experimental & molecular medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (promoter binding, genetic knockdown, metabolic assays, apoptosis), single lab","pmids":["34876693"],"is_preprint":false},{"year":2021,"finding":"Alu-element-mediated gross deletion involving exons 1–9 of BCKDHA causes MSUD in a compound heterozygous patient; the deletion breakpoints were mapped within microhomologous sequences in two Alu elements, establishing Alu-mediated recombination as the causative mechanism — the first report of Alu-mediated rearrangement at BCKDHA.","method":"Targeted capture sequencing, real-time PCR CNV analysis, whole genome sequencing, long-range PCR, Sanger sequencing to map deletion breakpoints","journal":"Clinica chimica acta; international journal of clinical chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — multiple sequencing methods converging on breakpoint mapping, mechanistic inference from Alu microhomology, single case/lab","pmids":["33607070"],"is_preprint":false},{"year":2022,"finding":"A paracentric inversion of chromosome 19 that disrupts intron 1 of BCKDHA causes classic MSUD in compound heterozygosity with a missense variant (p.Ala253Thr); the inversion was identified by whole-genome sequencing and validated by FISH, and the breakpoint junction sequence was characterized, providing mechanistic insight into structural rearrangement at this locus.","method":"Whole-genome sequencing, FISH, junction-specific PCR, Sanger sequencing","journal":"JIMD reports","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — multiple orthogonal methods for structural characterization, single case, single lab","pmids":["36341163"],"is_preprint":false},{"year":2023,"finding":"BCKDHA promotes melanoma cell proliferation, invasion, migration in vitro and tumor growth in vivo; mechanistically, BCKDHA upregulates the expression of lipogenic enzymes FASN and ATP-citrate lyase (ACLY), which mediate its oncogenic role, as demonstrated by RNA sequencing and functional rescue experiments.","method":"In vitro cell biology (knockdown/overexpression), in vivo xenograft model, RNA sequencing, immunohistochemistry, bioinformatics","journal":"Experimental dermatology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional knockdown/overexpression with in vivo validation, RNA-seq mechanistic follow-up, single lab","pmids":["37377173"],"is_preprint":false},{"year":2024,"finding":"BCKDK regulates hepatic gluconeogenesis independently of BCKDHA: liver-specific BCKDK knockout inhibits hepatic glucose production and gluconeogenic enzyme expression, whereas liver-specific BCKDHA knockout has no effect on gluconeogenesis. Mechanistically, BT2-mediated BCKDK inhibition attenuates interaction of CREB with CREB-binding protein and promotes FOXO1 ubiquitination and degradation, establishing a BCKDHA-independent pathway for BCKDK in glucose metabolism.","method":"Liver-specific knockout mice (BCKDK and BCKDHA), primary hepatocyte experiments, BT2 inhibitor treatment, BCKDK overexpression, co-immunoprecipitation (CREB–CBP interaction), ubiquitination assay for FOXO1","journal":"Cell death & disease","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — genetic KO of both BCKDK and BCKDHA in parallel, primary hepatocyte mechanistic experiments, Co-IP and ubiquitination assays, multiple orthogonal methods in single study clearly distinguishing BCKDHA-dependent vs. -independent roles","pmids":["39389936"],"is_preprint":false},{"year":2024,"finding":"Dephosphorylation (activation) of BCKDHA promotes BCAA catabolism and renders cancer cells resistant to X-irradiation by maintaining ATP levels and mitigating DNA damage (mitotic catastrophe and residual double-strand breaks). X-irradiation dose-dependently dephosphorylates BCKDHA, suggesting BCKDH complex activation; BCKDHA knockdown increases radiosensitivity.","method":"X-irradiation of cancer cells, BCKDHA phosphorylation state analysis, BCKDHA knockdown, measurement of ATP levels, mitotic catastrophe, and residual DSBs","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic knockdown with multiple phenotypic readouts (radiosensitivity, ATP, DSBs), mechanistic link through phosphorylation state, single lab","pmids":["39672007"],"is_preprint":false},{"year":2025,"finding":"PRSS55 (testis-specific serine protease) physically interacts with both BCKDK and BCKDHA in mouse testes and sperm, as validated by LC-MS/MS proteomics and Co-IP; loss of PRSS55 leads to accumulation of BCAAs (valine, leucine, isoleucine) and impaired mitochondrial function/ATP production in sperm, establishing PRSS55 as a regulator of BCAA catabolism upstream of the BCKDK–BCKDHA axis.","method":"Prss55 knockout mice, proteomics (LC-MS/MS), metabolomics, Co-IP, immunofluorescence, immunoblotting, mitochondrial function assays (ATP, membrane potential)","journal":"Cell & bioscience","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — Co-IP interaction validated by MS, KO mouse with metabolomics and mitochondrial functional readouts, multiple orthogonal methods in single study","pmids":["41444608"],"is_preprint":false},{"year":2025,"finding":"Dual-gene AAV9 vector (rAAV9.hA-BiP-hB) delivering codon-optimized BCKDHA and BCKDHB restores BCKDH holoenzyme activity in BCKDHA-knockout HEK293T cells and rescues perinatal lethality, normalizes growth, and stabilizes MSUD biomarkers in both Bckdha and Bckdhb mouse models and a newborn calf with BCKDHA c.248C>T. Coordinated BCKDHA and BCKDHB coexpression is required for holoenzyme activity, demonstrating that both E1α and E1β subunits are necessary for functional BCKDH complex assembly.","method":"AAV9 gene delivery, BCKDH holoenzyme activity assay in HEK293T cells, Bckdha/Bckdhb knockout mouse models, natural bovine MSUD model, biochemical and growth outcome measures","journal":"Science translational medicine","confidence":"High","confidence_rationale":"Tier 1 / Strong — enzymatic reconstitution in cell line plus rescue in two KO mouse models and a natural disease animal model; multiple independent model systems validate holoenzyme assembly requirement","pmids":["40009698"],"is_preprint":false},{"year":2026,"finding":"In Bckdha−/− mice, BCKDH deficiency causes a 9-fold elevation of brain 2-ketoisocaproate, cerebral depletion of glutamate and glutamine, and disruption of TCA cycle and ketone body metabolism; these arise from reversal of branched-chain aminotransferase 2 (BCAT2) flux and destabilization of glutamate–2-ketoglutarate mass balance. Systemic AAV9 dual-gene therapy (A-BiP-B encoding BCKDHA and BCKDHB) partially restored cerebral BCKDHA mRNA and brought brain neurochemical endpoints within wild-type range, demonstrating that BCKDHA is required for central nervous system metabolic homeostasis beyond peripheral amino acid control.","method":"Bckdha−/− mouse model, paired serum-brain metabolomics, AAV9 gene therapy rescue, RT-qPCR for BCKDHA mRNA in brain","journal":"Molecular therapy : the journal of the American Society of Gene Therapy","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — KO mouse with comprehensive paired metabolomics and gene therapy rescue; mechanistic pathway (BCAT2 flux reversal, glutamate depletion) defined by metabolomic data in single rigorous study","pmids":["42136029"],"is_preprint":false}],"current_model":"BCKDHA encodes the E1α subunit of the mitochondrial branched-chain α-ketoacid dehydrogenase (BCKDH) complex; it is phosphorylated (inactivated) by BCKDK and must be co-expressed with E1β (BCKDHB) for holoenzyme assembly and decarboxylation of ketoacid derivatives of leucine, isoleucine, and valine; its dephosphorylation/activation channels BCAA-derived carbon into the TCA cycle, maintaining cellular ATP levels and neurochemical homeostasis; BCKDHA expression is epigenetically regulated at its promoter by the histone demethylase KDM3A; PRSS55 interacts physically with the BCKDK–BCKDHA axis to regulate BCAA catabolism in sperm; and in cancer contexts BCKDHA supports tumor progression by promoting lipogenesis (via FASN/ACLY) and radiation resistance via ATP-dependent DNA damage mitigation."},"narrative":{"mechanistic_narrative":"BCKDHA encodes the E1α subunit of the mitochondrial branched-chain α-ketoacid dehydrogenase (BCKDH) complex, the committed enzymatic step that decarboxylates the ketoacid derivatives of leucine, isoleucine, and valine and channels branched-chain amino acid (BCAA)-derived carbon into the TCA cycle [PMID:40009698, PMID:42136029]. Functional holoenzyme assembly requires coordinated coexpression of E1α (BCKDHA) and E1β (BCKDHB): codon-optimized dual-gene delivery of both subunits is necessary and sufficient to reconstitute BCKDH activity in BCKDHA-null cells and to rescue perinatal lethality and MSUD biomarkers in animal models [PMID:40009698]. Loss of BCKDHA function causes maple syrup urine disease (MSUD), arising from diverse lesions including nonsense, missense, and splice mutations as well as large structural rearrangements at the 19q13 locus [PMID:10694918, PMID:20431954, PMID:33607070, PMID:36341163]. Enzyme activity is governed by the phosphorylation state of the E1α subunit; dephosphorylation activates the complex, and in cancer this activation sustains BCAA catabolism, ATP levels, and radiation resistance, while BCKDHA knockdown increases radiosensitivity [PMID:39672007]. BCKDHA transcription is epigenetically controlled through KDM3A binding at its promoter, and its loss reduces mitochondrial TCA-cycle fueling and drives apoptosis in EGFR-mutant tumor cells [PMID:34876693]; in melanoma BCKDHA promotes proliferation and invasion by upregulating the lipogenic enzymes FASN and ACLY [PMID:37377173]. Beyond peripheral amino acid handling, BCKDHA is required for central nervous system metabolic homeostasis, since its loss elevates brain 2-ketoisocaproate and depletes glutamate/glutamine via reversal of BCAT2 flux [PMID:42136029]. The E1α subunit also lies downstream of regulatory inputs from PRSS55 in sperm and is functionally distinct from BCKDK's BCKDHA-independent control of hepatic gluconeogenesis [PMID:39389936, PMID:41444608].","teleology":[{"year":1989,"claim":"Establishing the chromosomal location of BCKDHA was the first step in defining it as a discrete genetic locus for the E1α subunit and a candidate for inherited metabolic disease.","evidence":"In situ hybridization with 3H-labeled cDNA mapping to 19q13.1–q13.2","pmids":["2805821"],"confidence":"Medium","gaps":["No functional or expression data","Did not define gene structure or regulation"]},{"year":1993,"claim":"Dissecting the gene's exon structure and promoter revealed how BCKDHA transcription is controlled, including TATA-less initiation and cell-type-specific regulatory elements.","evidence":"Genomic cloning, sequencing, and deletion-reporter luciferase assays in Hep-G2 and CHO cells","pmids":["8463340"],"confidence":"High","gaps":["Trans-acting factors binding the promoter not identified","In vivo relevance of cell-type differences unresolved"]},{"year":1998,"claim":"Linking a specific nonsense mutation to absent enzyme activity established BCKDHA loss-of-function as causative for MSUD.","evidence":"Mutation analysis and enzyme assay in amniocytes from a consanguineous MSUD pedigree (R242X)","pmids":["10694918"],"confidence":"Medium","gaps":["Single pedigree","No biochemical reconstitution of the mutant protein"]},{"year":2008,"claim":"Characterizing a large intragenic deletion and its breakpoint motif extended the MSUD mutational spectrum to structural rearrangements driven by non-homologous recombination.","evidence":"Long-range PCR and breakpoint sequencing in an MSUD patient (exons 2–4 deletion)","pmids":["19085071"],"confidence":"Medium","gaps":["Single case","Recombination mechanism inferred from motif rather than directly demonstrated"]},{"year":2009,"claim":"Identifying a founder mutation and recurrent hotspot explained population-level MSUD incidence and the recurrence of certain BCKDHA lesions.","evidence":"Microsatellite haplotyping flanking BCKDHA in Portuguese Gypsy and other populations (c.117delC)","pmids":["19456321"],"confidence":"Medium","gaps":["No functional characterization of the frameshift allele","Hotspot mechanism not molecularly defined"]},{"year":2010,"claim":"Demonstrating that an intronic variant creates a cryptic splice site triggering NMD, with residual normal transcript, explained genotype–phenotype correlation for milder variant MSUD.","evidence":"Patient mRNA analysis, emetine rescue, and minigene splicing assay (c.288+9C>T)","pmids":["20431954"],"confidence":"High","gaps":["Quantitative threshold of residual activity for phenotype not defined","Single patient context"]},{"year":2011,"claim":"Structural modeling of missense mutations proposed how residue changes near the helical and cofactor/manganese-binding regions impair E1α.","evidence":"Sanger sequencing and PyMOL structural modeling of p.L103P and p.R265P in a Chinese MSUD patient","pmids":["22145486"],"confidence":"Low","gaps":["Computational modeling only, no in vitro functional validation","Effect on holoenzyme assembly untested"]},{"year":2021,"claim":"Identifying KDM3A as an epigenetic regulator of BCKDHA established transcriptional control of the gene and linked its expression to mitochondrial energy supply in EGFR-mutant cancer.","evidence":"BIX01294 treatment, BCKDHA knockdown, KDM3A promoter chromatin binding, and metabolic/apoptosis assays in NSCLC cells","pmids":["34876693"],"confidence":"Medium","gaps":["Single lab and cancer context","Direct KDM3A demethylase activity at the locus not biochemically resolved"]},{"year":2021,"claim":"Mapping an Alu-mediated gross deletion of the entire gene further broadened the structural mutation landscape underlying MSUD.","evidence":"Targeted capture, WGS, CNV PCR, and breakpoint sequencing in a compound heterozygous MSUD patient (exons 1–9 deletion)","pmids":["33607070"],"confidence":"Medium","gaps":["Single case","Recombination mechanism inferred from microhomology"]},{"year":2022,"claim":"Characterizing a paracentric inversion disrupting intron 1 demonstrated that non-deletional structural rearrangements can also cause classic MSUD.","evidence":"WGS, FISH, and junction-specific sequencing in a compound heterozygous patient","pmids":["36341163"],"confidence":"Medium","gaps":["Single case","Transcriptional consequence of the inversion not directly assayed"]},{"year":2023,"claim":"Defining a lipogenic axis showed that BCKDHA can act as a pro-tumorigenic gene by upregulating FASN and ACLY, extending its role beyond catabolic housekeeping.","evidence":"Knockdown/overexpression, xenografts, RNA-seq, and rescue experiments in melanoma","pmids":["37377173"],"confidence":"Medium","gaps":["Mechanism linking BCKDHA to FASN/ACLY induction undefined","Single tumor type and lab"]},{"year":2024,"claim":"Parallel liver-specific knockouts dissociated BCKDK's control of gluconeogenesis from BCKDHA, showing BCKDK has a BCKDHA-independent role in glucose metabolism.","evidence":"Liver-specific BCKDK and BCKDHA knockout mice, BT2 treatment, CREB–CBP Co-IP, and FOXO1 ubiquitination assays","pmids":["39389936"],"confidence":"High","gaps":["Establishes what BCKDHA does NOT do, not a new BCKDHA function","Tissue specificity of the dissociation in non-hepatic contexts unknown"]},{"year":2024,"claim":"Linking the phosphorylation state of E1α to radiation resistance showed that BCKDH activation sustains ATP and mitigates DNA damage in cancer cells.","evidence":"X-irradiation, BCKDHA phosphorylation analysis, knockdown, and ATP/DSB/mitotic-catastrophe readouts in cancer cells","pmids":["39672007"],"confidence":"Medium","gaps":["Phosphatase mediating dephosphorylation not identified","Mechanism connecting ATP to DSB repair not resolved"]},{"year":2025,"claim":"Identifying PRSS55 as a physical partner of the BCKDK–BCKDHA axis placed E1α within a tissue-specific regulatory complex controlling sperm BCAA catabolism and mitochondrial energetics.","evidence":"Prss55 knockout mice, LC-MS/MS proteomics, Co-IP, metabolomics, and mitochondrial function assays in testes/sperm","pmids":["41444608"],"confidence":"High","gaps":["Molecular consequence of PRSS55 binding on BCKDHA activity unresolved","Protease substrate relationship not defined"]},{"year":2025,"claim":"Demonstrating that coordinated E1α/E1β coexpression reconstitutes holoenzyme activity and rescues disease across models established the obligate two-subunit requirement and a gene therapy strategy.","evidence":"Dual-gene AAV9 delivery, holoenzyme activity assay in BCKDHA-KO HEK293T, Bckdha/Bckdhb KO mice, and a natural bovine MSUD model","pmids":["40009698"],"confidence":"High","gaps":["Long-term durability of rescue not addressed","Stoichiometry and assembly intermediates not structurally resolved"]},{"year":2026,"claim":"Paired serum-brain metabolomics in knockout mice defined a CNS-specific consequence of BCKDHA loss—BCAT2 flux reversal and glutamate/glutamine depletion—and showed gene therapy normalizes brain neurochemistry.","evidence":"Bckdha−/− mice, paired metabolomics, AAV9 dual-gene rescue, and brain BCKDHA RT-qPCR","pmids":["42136029"],"confidence":"High","gaps":["Cell-type resolution of brain metabolic changes lacking","Causal link from neurochemical shifts to neurological phenotype not fully traced"]},{"year":null,"claim":"How the phosphorylation/dephosphorylation cycle of E1α is integrated with upstream regulators (PRSS55, KDM3A) and tissue-specific signaling to tune BCKDH activity dynamically remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["Phosphatase activating BCKDHA in cancer not identified","Structural basis of E1α/E1β holoenzyme assembly and cofactor coordination not experimentally solved","Mechanism linking BCKDHA to lipogenic enzyme induction undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016829","term_label":"lyase activity","supporting_discovery_ids":[2,14]},{"term_id":"GO:0016491","term_label":"oxidoreductase activity","supporting_discovery_ids":[14,15]}],"localization":[{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[7,13]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[14,15]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[2,14]}],"complexes":["branched-chain α-ketoacid dehydrogenase (BCKDH) complex"],"partners":["BCKDHB","BCKDK","PRSS55","KDM3A"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P12694","full_name":"2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial","aliases":["Branched-chain alpha-keto acid dehydrogenase E1 component alpha chain","BCKDE1A","BCKDH E1-alpha"],"length_aa":445,"mass_kda":50.5,"function":"Together with BCKDHB forms the heterotetrameric E1 subunit of the mitochondrial branched-chain alpha-ketoacid dehydrogenase (BCKD) complex. The BCKD complex catalyzes the multi-step oxidative decarboxylation of alpha-ketoacids derived from the branched-chain amino-acids valine, leucine and isoleucine producing CO2 and acyl-CoA which is subsequently utilized to produce energy. The E1 subunit catalyzes the first step with the decarboxylation of the alpha-ketoacid forming an enzyme-product intermediate. A reductive acylation mediated by the lipoylamide cofactor of E2 extracts the acyl group from the E1 active site for the next step of the reaction","subcellular_location":"Mitochondrion matrix","url":"https://www.uniprot.org/uniprotkb/P12694/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/BCKDHA","classification":"Not Classified","n_dependent_lines":2,"n_total_lines":1208,"dependency_fraction":0.0016556291390728477},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/BCKDHA","total_profiled":1310},"omim":[{"mim_id":"620699","title":"MAPLE SYRUP URINE DISEASE, TYPE II; MSUD2","url":"https://www.omim.org/entry/620699"},{"mim_id":"620698","title":"MAPLE SYRUP URINE DISEASE, TYPE IB; MSUD1B","url":"https://www.omim.org/entry/620698"},{"mim_id":"614901","title":"BRANCHED-CHAIN ALPHA-KETO ACID DEHYDROGENASE KINASE; BCKDK","url":"https://www.omim.org/entry/614901"},{"mim_id":"614462","title":"HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES; HGCLAS","url":"https://www.omim.org/entry/614462"},{"mim_id":"611065","title":"PROTEIN PHOSPHATASE, MAGNESIUM/MANGANESE-DEPENDENT, 1K; PPM1K","url":"https://www.omim.org/entry/611065"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/BCKDHA"},"hgnc":{"alias_symbol":["MSU"],"prev_symbol":["OVD1A"]},"alphafold":{"accession":"P12694","domains":[{"cath_id":"3.40.50.970","chopping":"90-339_346-398","consensus_level":"high","plddt":98.1021,"start":90,"end":398},{"cath_id":"-","chopping":"404-436","consensus_level":"high","plddt":98.4467,"start":404,"end":436}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P12694","model_url":"https://alphafold.ebi.ac.uk/files/AF-P12694-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P12694-F1-predicted_aligned_error_v6.png","plddt_mean":91.56},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=BCKDHA","jax_strain_url":"https://www.jax.org/strain/search?query=BCKDHA"},"sequence":{"accession":"P12694","fasta_url":"https://rest.uniprot.org/uniprotkb/P12694.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P12694/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P12694"}},"corpus_meta":[{"pmid":"31455356","id":"PMC_31455356","title":"Curcumin attenuates MSU crystal-induced inflammation by inhibiting the degradation of IκBα and blocking mitochondrial damage.","date":"2019","source":"Arthritis research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/31455356","citation_count":124,"is_preprint":false},{"pmid":"28068647","id":"PMC_28068647","title":"Berberine, an isoquinoline alkaloid suppresses TXNIP mediated NLRP3 inflammasome activation in MSU crystal stimulated RAW 264.7 macrophages through the upregulation of Nrf2 transcription factor and alleviates MSU crystal induced inflammation in rats.","date":"2017","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/28068647","citation_count":97,"is_preprint":false},{"pmid":"35812134","id":"PMC_35812134","title":"Palmatine Protects Against MSU-Induced Gouty Arthritis via Regulating the NF-κB/NLRP3 and Nrf2 Pathways.","date":"2022","source":"Drug design, development and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/35812134","citation_count":84,"is_preprint":false},{"pmid":"33130474","id":"PMC_33130474","title":"Celastrol ameliorates Propionibacterium acnes/LPS-induced liver damage and MSU-induced gouty arthritis via inhibiting K63 deubiquitination of NLRP3.","date":"2020","source":"Phytomedicine : international journal of phytotherapy and phytopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/33130474","citation_count":69,"is_preprint":false},{"pmid":"10049377","id":"PMC_10049377","title":"A novel reduced flavin mononucleotide-dependent methanesulfonate sulfonatase encoded by the sulfur-regulated msu operon of Pseudomonas aeruginosa.","date":"1999","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/10049377","citation_count":68,"is_preprint":false},{"pmid":"34482265","id":"PMC_34482265","title":"Tetrahydropalmatine attenuates MSU crystal-induced gouty arthritis by inhibiting ROS-mediated NLRP3 inflammasome activation.","date":"2021","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/34482265","citation_count":52,"is_preprint":false},{"pmid":"30039428","id":"PMC_30039428","title":"Changes of Treg/Th17 Ratio in Spleen of Acute Gouty Arthritis Rat Induced by MSU Crystals.","date":"2018","source":"Inflammation","url":"https://pubmed.ncbi.nlm.nih.gov/30039428","citation_count":45,"is_preprint":false},{"pmid":"36109143","id":"PMC_36109143","title":"Type II collagen facilitates gouty arthritis by regulating MSU crystallisation and inflammatory cell recruitment.","date":"2022","source":"Annals of the rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/36109143","citation_count":42,"is_preprint":false},{"pmid":"32104502","id":"PMC_32104502","title":"A mouse model of MSU-induced acute inflammation in vivo suggests imiquimod-dependent targeting of Il-1β as relevant therapy for gout patients.","date":"2020","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/32104502","citation_count":40,"is_preprint":false},{"pmid":"29482609","id":"PMC_29482609","title":"MicroRNA-302b negatively regulates IL-1β production in response to MSU crystals by targeting IRAK4 and EphA2.","date":"2018","source":"Arthritis research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/29482609","citation_count":40,"is_preprint":false},{"pmid":"26547220","id":"PMC_26547220","title":"IL-37 inhibits the production of pro-inflammatory cytokines in MSU crystal-induced inflammatory response.","date":"2015","source":"Clinical rheumatology","url":"https://pubmed.ncbi.nlm.nih.gov/26547220","citation_count":40,"is_preprint":false},{"pmid":"1549589","id":"PMC_1549589","title":"Malignant transformation of human fibroblast cell strain MSU-1.1 by (+-)-7 beta,8 alpha-dihydroxy-9 alpha,10 alpha-epoxy-7,8,9,10-tetrahydrobenzo [a]pyrene.","date":"1992","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/1549589","citation_count":35,"is_preprint":false},{"pmid":"33038330","id":"PMC_33038330","title":"Anti-inflammatory and anti-gouty-arthritic effect of free Ginsenoside Rb1 and nano Ginsenoside Rb1 against MSU induced gouty arthritis in experimental animals.","date":"2020","source":"Chemico-biological interactions","url":"https://pubmed.ncbi.nlm.nih.gov/33038330","citation_count":35,"is_preprint":false},{"pmid":"37756161","id":"PMC_37756161","title":"MSU crystal deposition contributes to inflammation and immune responses in gout remission.","date":"2023","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/37756161","citation_count":34,"is_preprint":false},{"pmid":"33006110","id":"PMC_33006110","title":"Management of Gout-associated MSU crystals-induced NLRP3 inflammasome activation by procyanidin B2: targeting IL-1β and Cathepsin B in macrophages.","date":"2020","source":"Inflammopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/33006110","citation_count":34,"is_preprint":false},{"pmid":"30537632","id":"PMC_30537632","title":"Resveratrol attenuates the MSU crystal-induced inflammatory response through the inhibition of TAK1 activity.","date":"2018","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/30537632","citation_count":29,"is_preprint":false},{"pmid":"20395644","id":"PMC_20395644","title":"Differences in MSU-induced superoxide responses by neutrophils from gout subjects compared to healthy controls and a role for environmental inflammatory cytokines and hyperuricemia in neutrophil function and survival.","date":"2010","source":"The Journal of rheumatology","url":"https://pubmed.ncbi.nlm.nih.gov/20395644","citation_count":28,"is_preprint":false},{"pmid":"36569930","id":"PMC_36569930","title":"Lipoxin A4 attenuates MSU-crystal-induced NLRP3 inflammasome activation through suppressing Nrf2 thereby increasing TXNRD2.","date":"2022","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/36569930","citation_count":27,"is_preprint":false},{"pmid":"33967792","id":"PMC_33967792","title":"β-Caryophyllene Ameliorates MSU-Induced Gouty Arthritis and Inflammation Through Inhibiting NLRP3 and NF-κB Signal Pathway: In Silico and In Vivo.","date":"2021","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/33967792","citation_count":24,"is_preprint":false},{"pmid":"33517224","id":"PMC_33517224","title":"Curcumin analogue AI-44 alleviates MSU-induced gouty arthritis in mice via inhibiting cathepsin B-mediated NLRP3 inflammasome activation.","date":"2021","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/33517224","citation_count":24,"is_preprint":false},{"pmid":"19655406","id":"PMC_19655406","title":"Effects of extracts from Paederia scandens (LOUR.) MERRILL (Rubiaceae) on MSU crystal-induced rats gouty arthritis.","date":"2009","source":"The American journal of Chinese medicine","url":"https://pubmed.ncbi.nlm.nih.gov/19655406","citation_count":23,"is_preprint":false},{"pmid":"36338340","id":"PMC_36338340","title":"Dynamin-Related Protein 1 Is Involved in Mitochondrial Damage, Defective Mitophagy, and NLRP3 Inflammasome Activation Induced by MSU Crystals.","date":"2022","source":"Oxidative medicine and cellular longevity","url":"https://pubmed.ncbi.nlm.nih.gov/36338340","citation_count":22,"is_preprint":false},{"pmid":"34586567","id":"PMC_34586567","title":"Effects of Gentiopicroside on activation of NLRP3 inflammasome in acute gouty arthritis mice induced by MSU.","date":"2021","source":"Journal of natural medicines","url":"https://pubmed.ncbi.nlm.nih.gov/34586567","citation_count":21,"is_preprint":false},{"pmid":"39939033","id":"PMC_39939033","title":"Anemoside B4 targets NEK7 to inhibit NLRP3 inflammasome activation and alleviate MSU-induced acute gouty arthritis by modulating the NF-κB signaling pathway.","date":"2025","source":"Phytomedicine : international journal of phytotherapy and phytopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/39939033","citation_count":19,"is_preprint":false},{"pmid":"36225929","id":"PMC_36225929","title":"POP1 inhibits MSU-induced inflammasome activation and ameliorates gout.","date":"2022","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/36225929","citation_count":19,"is_preprint":false},{"pmid":"33135192","id":"PMC_33135192","title":"Icariin alleviates MSU-induced rat GA models through NF-κB/NALP3 pathway.","date":"2020","source":"Cell biochemistry and function","url":"https://pubmed.ncbi.nlm.nih.gov/33135192","citation_count":19,"is_preprint":false},{"pmid":"31676289","id":"PMC_31676289","title":"MSU Crystals induce sterile IL-1β secretion via P2X7 receptor activation and HMGB1 release.","date":"2019","source":"Biochimica et biophysica acta. General subjects","url":"https://pubmed.ncbi.nlm.nih.gov/31676289","citation_count":19,"is_preprint":false},{"pmid":"37209866","id":"PMC_37209866","title":"Polydatin ameliorates inflammation and oxidative stress associated with MSU-induced gouty arthritis in mice by regulating PPAR-γ and ferritin activation.","date":"2023","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/37209866","citation_count":19,"is_preprint":false},{"pmid":"30228974","id":"PMC_30228974","title":"Fourteen new mutations of BCKDHA, BCKDHB and DBT genes associated with maple syrup urine disease (MSUD) in Malaysian population.","date":"2018","source":"Molecular genetics and metabolism reports","url":"https://pubmed.ncbi.nlm.nih.gov/30228974","citation_count":18,"is_preprint":false},{"pmid":"10945617","id":"PMC_10945617","title":"Malignant transformation of human fibroblast cell strain MSU-1.1 by N-methyl-N-nitrosourea: evidence of elimination of p53 by homologous recombination.","date":"2000","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/10945617","citation_count":18,"is_preprint":false},{"pmid":"8463340","id":"PMC_8463340","title":"Characterization of the promoter-regulatory region and structural organization of E1 alpha gene (BCKDHA) of human branched-chain alpha-keto acid dehydrogenase complex.","date":"1993","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8463340","citation_count":17,"is_preprint":false},{"pmid":"26453840","id":"PMC_26453840","title":"Eleven novel mutations of the BCKDHA, BCKDHB and DBT genes associated with maple syrup urine disease in the Chinese population: Report on eight cases.","date":"2015","source":"European journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26453840","citation_count":17,"is_preprint":false},{"pmid":"32395118","id":"PMC_32395118","title":"1-Palmitoyl-2-Linoleoyl-3-Acetyl-rac-Glycerol (PLAG) Mitigates Monosodium Urate (MSU)-Induced Acute Gouty Inflammation in BALB/c Mice.","date":"2020","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/32395118","citation_count":17,"is_preprint":false},{"pmid":"30637441","id":"PMC_30637441","title":"Suppression of Syk activation by resveratrol inhibits MSU crystal-induced inflammation in human monocytes.","date":"2019","source":"Journal of molecular medicine (Berlin, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/30637441","citation_count":17,"is_preprint":false},{"pmid":"28417071","id":"PMC_28417071","title":"Twenty novel mutations in BCKDHA, BCKDHB and DBT genes in a cohort of 52 Saudi Arabian patients with maple syrup urine disease.","date":"2017","source":"Molecular genetics and metabolism reports","url":"https://pubmed.ncbi.nlm.nih.gov/28417071","citation_count":16,"is_preprint":false},{"pmid":"20620045","id":"PMC_20620045","title":"Biological hydrogen production by the algal biomass Chlorella vulgaris MSU 01 strain isolated from pond sediment.","date":"2011","source":"Bioresource technology","url":"https://pubmed.ncbi.nlm.nih.gov/20620045","citation_count":16,"is_preprint":false},{"pmid":"38066599","id":"PMC_38066599","title":"Ozone alleviates MSU-induced acute gout pain via upregulating AMPK/GAS6/MerTK/SOCS3 signaling pathway.","date":"2023","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/38066599","citation_count":15,"is_preprint":false},{"pmid":"34876693","id":"PMC_34876693","title":"BIX01294 inhibits EGFR signaling in EGFR-mutant lung adenocarcinoma cells through a BCKDHA-mediated reduction in the EGFR level.","date":"2021","source":"Experimental & molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34876693","citation_count":15,"is_preprint":false},{"pmid":"36686377","id":"PMC_36686377","title":"P2X7R Mediates the Synergistic Effect of ATP and MSU Crystals to Induce Acute Gouty Arthritis.","date":"2023","source":"Oxidative medicine and cellular longevity","url":"https://pubmed.ncbi.nlm.nih.gov/36686377","citation_count":15,"is_preprint":false},{"pmid":"30941135","id":"PMC_30941135","title":"Alpha2B-Adrenergic Receptor Regulates Neutrophil Recruitment in MSU-Induced Peritoneal Inflammation.","date":"2019","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30941135","citation_count":15,"is_preprint":false},{"pmid":"33335263","id":"PMC_33335263","title":"The novel rexinoid MSU-42011 is effective for the treatment of preclinical Kras-driven lung cancer.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/33335263","citation_count":14,"is_preprint":false},{"pmid":"32236574","id":"PMC_32236574","title":"Total saponin of Dioscorea collettii attenuates MSU crystal‑induced inflammation via inhibiting the activation of the NALP3 inflammasome and caspase‑1 in THP‑1 macrophages.","date":"2020","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/32236574","citation_count":14,"is_preprint":false},{"pmid":"39605016","id":"PMC_39605016","title":"Resolution of acute inflammation induced by monosodium urate crystals (MSU) through neutrophil extracellular trap-MSU aggregate-mediated negative signaling.","date":"2024","source":"Journal of inflammation (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/39605016","citation_count":13,"is_preprint":false},{"pmid":"30863362","id":"PMC_30863362","title":"IL-33 Ameliorates the Development of MSU-Induced Inflammation Through Expanding MDSCs-Like Cells.","date":"2019","source":"Frontiers in endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/30863362","citation_count":13,"is_preprint":false},{"pmid":"37498355","id":"PMC_37498355","title":"Discovery of a selective NLRP3-targeting compound with therapeutic activity in MSU-induced peritonitis and DSS-induced acute intestinal inflammation.","date":"2023","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/37498355","citation_count":13,"is_preprint":false},{"pmid":"37573689","id":"PMC_37573689","title":"Autophagy induced by PP121 alleviates MSU crystal-induced acute gouty arthritis via inhibition of the NLRP3 inflammasome.","date":"2023","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/37573689","citation_count":12,"is_preprint":false},{"pmid":"2805821","id":"PMC_2805821","title":"Localization of the human gene for the El alpha subunit of branched chain keto acid dehydrogenase (BCKDHA) to chromosome 19q13.1----q13.2.","date":"1989","source":"Cytogenetics and cell genetics","url":"https://pubmed.ncbi.nlm.nih.gov/2805821","citation_count":12,"is_preprint":false},{"pmid":"34335573","id":"PMC_34335573","title":"Targeting Tristetraprolin Expression or Functional Activity Regulates Inflammatory Response Induced by MSU Crystals.","date":"2021","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/34335573","citation_count":11,"is_preprint":false},{"pmid":"36226520","id":"PMC_36226520","title":"MicroRNA-486-5p suppresses inflammatory response by targeting FOXO1 in MSU-treated macrophages.","date":"2022","source":"Autoimmunity","url":"https://pubmed.ncbi.nlm.nih.gov/36226520","citation_count":10,"is_preprint":false},{"pmid":"36734707","id":"PMC_36734707","title":"Dimethyl fumarate attenuates MSU-induced gouty arthritis by inhibiting NLRP3 inflammasome activation and oxidative stress.","date":"2023","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36734707","citation_count":10,"is_preprint":false},{"pmid":"19456321","id":"PMC_19456321","title":"Revisiting MSUD in Portuguese Gypsies: evidence for a founder mutation and for a mutational hotspot within the BCKDHA gene.","date":"2009","source":"Annals of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19456321","citation_count":10,"is_preprint":false},{"pmid":"31312662","id":"PMC_31312662","title":"Decreased Expression of CD14 in MSU-Mediated Inflammation May Be Associated with Spontaneous Remission of Acute Gout.","date":"2019","source":"Journal of immunology research","url":"https://pubmed.ncbi.nlm.nih.gov/31312662","citation_count":10,"is_preprint":false},{"pmid":"38078724","id":"PMC_38078724","title":"The Mycobacterium tuberculosis MmpL3 inhibitor MSU-43085 is active in a mouse model of infection.","date":"2023","source":"Microbiology spectrum","url":"https://pubmed.ncbi.nlm.nih.gov/38078724","citation_count":9,"is_preprint":false},{"pmid":"34284768","id":"PMC_34284768","title":"Effects of Stephania hainanensis alkaloids on MSU-induced acute gouty arthritis in mice.","date":"2021","source":"BMC complementary medicine and therapies","url":"https://pubmed.ncbi.nlm.nih.gov/34284768","citation_count":9,"is_preprint":false},{"pmid":"21844576","id":"PMC_21844576","title":"Three Korean patients with maple syrup urine disease: four novel mutations in the BCKDHA gene.","date":"2011","source":"Annals of clinical and laboratory science","url":"https://pubmed.ncbi.nlm.nih.gov/21844576","citation_count":9,"is_preprint":false},{"pmid":"30806957","id":"PMC_30806957","title":"MSU Crystals Enhance TDB-Mediated Inflammatory Macrophage IL-1β Secretion.","date":"2019","source":"Inflammation","url":"https://pubmed.ncbi.nlm.nih.gov/30806957","citation_count":9,"is_preprint":false},{"pmid":"37715438","id":"PMC_37715438","title":"Resveratrol alleviates MSU-induced gouty arthritis in rats through inhibition of HIF-1α- and NLRP3-derived IL-1β secretion in macrophages.","date":"2023","source":"Cellular and molecular biology (Noisy-le-Grand, France)","url":"https://pubmed.ncbi.nlm.nih.gov/37715438","citation_count":9,"is_preprint":false},{"pmid":"9806600","id":"PMC_9806600","title":"Dose-dependent transformation of cells of human fibroblast cell strain MSU-1.1 by cobalt-60 gamma radiation and characterization of the transformed cells.","date":"1998","source":"Radiation research","url":"https://pubmed.ncbi.nlm.nih.gov/9806600","citation_count":9,"is_preprint":false},{"pmid":"34721647","id":"PMC_34721647","title":"Total Saponin of Dioscorea collettii Attenuates MSU Crystal-Induced Inflammation by Inhibiting the Activation of the TLR4/NF-κB Signaling Pathway.","date":"2021","source":"Evidence-based complementary and alternative medicine : eCAM","url":"https://pubmed.ncbi.nlm.nih.gov/34721647","citation_count":9,"is_preprint":false},{"pmid":"37377173","id":"PMC_37377173","title":"BCKDHA contributes to melanoma progression by promoting the expressions of lipogenic enzymes FASN and ACLY.","date":"2023","source":"Experimental dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/37377173","citation_count":8,"is_preprint":false},{"pmid":"37996809","id":"PMC_37996809","title":"Maresin1 ameliorates MSU crystal-induced inflammation by upregulating Prdx5 expression.","date":"2023","source":"Molecular medicine (Cambridge, Mass.)","url":"https://pubmed.ncbi.nlm.nih.gov/37996809","citation_count":8,"is_preprint":false},{"pmid":"25178483","id":"PMC_25178483","title":"Increased level of MSU crystal-bound protein apolipoprotein A-I in acute gouty arthritis.","date":"2014","source":"Scandinavian journal of rheumatology","url":"https://pubmed.ncbi.nlm.nih.gov/25178483","citation_count":8,"is_preprint":false},{"pmid":"34965184","id":"PMC_34965184","title":"The protective effects of S14G-humanin (HNG) against mono-sodium urate (MSU) crystals- induced gouty arthritis.","date":"2022","source":"Bioengineered","url":"https://pubmed.ncbi.nlm.nih.gov/34965184","citation_count":8,"is_preprint":false},{"pmid":"36626932","id":"PMC_36626932","title":"Ouratea spectabilis and its Biflavanone Ouratein D Exert Potent Anti-inflammatory Activity in MSU Crystal-induced Gout in Mice.","date":"2023","source":"Planta medica","url":"https://pubmed.ncbi.nlm.nih.gov/36626932","citation_count":8,"is_preprint":false},{"pmid":"34002852","id":"PMC_34002852","title":"CD300a contributes to the resolution of articular inflammation triggered by MSU crystals by controlling neutrophil apoptosis.","date":"2021","source":"Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/34002852","citation_count":8,"is_preprint":false},{"pmid":"39175013","id":"PMC_39175013","title":"ML335 inhibits TWIK2 channel-mediated potassium efflux and attenuates mitochondrial damage in MSU crystal-induced inflammation.","date":"2024","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/39175013","citation_count":7,"is_preprint":false},{"pmid":"39215017","id":"PMC_39215017","title":"MSU crystallization promotes fibroblast proliferation and renal fibrosis in diabetic nephropathy via the ROS/SHP2/TGFβ pathway.","date":"2024","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/39215017","citation_count":7,"is_preprint":false},{"pmid":"39952005","id":"PMC_39952005","title":"Study on the effect and mechanism of ZeXie decoction in treating MSU-induced acute gouty arthritis model through PI3K-AKT-mTOR signaling pathway.","date":"2025","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/39952005","citation_count":7,"is_preprint":false},{"pmid":"36838278","id":"PMC_36838278","title":"Adaptation of Lacticaseibacillus rhamnosus CM MSU 529 to Aerobic Growth: A Proteomic Approach.","date":"2023","source":"Microorganisms","url":"https://pubmed.ncbi.nlm.nih.gov/36838278","citation_count":7,"is_preprint":false},{"pmid":"36477951","id":"PMC_36477951","title":"MicroRNA-181a regulates Treg functions via TGF-β1/Smad axis in the spleen of mice with acute gouty arthritis induced by MSU crystals.","date":"2022","source":"Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas","url":"https://pubmed.ncbi.nlm.nih.gov/36477951","citation_count":7,"is_preprint":false},{"pmid":"29306928","id":"PMC_29306928","title":"Four novel mutations of the BCKDHA, BCKDHB and DBT genes in Iranian patients with maple syrup urine disease.","date":"2018","source":"Journal of pediatric endocrinology & metabolism : JPEM","url":"https://pubmed.ncbi.nlm.nih.gov/29306928","citation_count":6,"is_preprint":false},{"pmid":"38940057","id":"PMC_38940057","title":"DUSP1 Mitigates MSU-Induced Immune Response in Gouty Arthritis Reinforcing Autophagy.","date":"2024","source":"Frontiers in bioscience (Landmark edition)","url":"https://pubmed.ncbi.nlm.nih.gov/38940057","citation_count":6,"is_preprint":false},{"pmid":"26451307","id":"PMC_26451307","title":"IL-1βR-dependent priming of antitumor CD4+ T cells and sustained antitumor immunity after peri-tumoral treatment with MSU and mycobacteria.","date":"2015","source":"Oncoimmunology","url":"https://pubmed.ncbi.nlm.nih.gov/26451307","citation_count":6,"is_preprint":false},{"pmid":"22145486","id":"PMC_22145486","title":"Identification of two novel BCKDHA mutations in a Chinese patient with maple syrup urine disease.","date":"2011","source":"Journal of pediatric endocrinology & metabolism : JPEM","url":"https://pubmed.ncbi.nlm.nih.gov/22145486","citation_count":6,"is_preprint":false},{"pmid":"19085071","id":"PMC_19085071","title":"Maple syrup urine disease due to a new large deletion at BCKDHA caused by non-homologous recombination.","date":"2008","source":"Journal of inherited metabolic disease","url":"https://pubmed.ncbi.nlm.nih.gov/19085071","citation_count":6,"is_preprint":false},{"pmid":"39389936","id":"PMC_39389936","title":"BCKDH kinase promotes hepatic gluconeogenesis independent of BCKDHA.","date":"2024","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/39389936","citation_count":5,"is_preprint":false},{"pmid":"40009698","id":"PMC_40009698","title":"BCKDHA-BCKDHB digenic gene therapy restores metabolic homeostasis in two mouse models and a calf with classic maple syrup urine disease.","date":"2025","source":"Science translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/40009698","citation_count":5,"is_preprint":false},{"pmid":"40567054","id":"PMC_40567054","title":"Triple-Enzyme Mimetic Manganese Nanozyme with Redox-Adaptive Catalysis for Synergistic MSU Degradation and Inflammation Resolution in Acute Gout.","date":"2025","source":"Advanced healthcare materials","url":"https://pubmed.ncbi.nlm.nih.gov/40567054","citation_count":5,"is_preprint":false},{"pmid":"34212036","id":"PMC_34212036","title":"Minimally Invasive Embedding of Saturated MSU Induces Persistent Gouty Arthritis in Modified Rat Model.","date":"2021","source":"BioMed research international","url":"https://pubmed.ncbi.nlm.nih.gov/34212036","citation_count":5,"is_preprint":false},{"pmid":"20431954","id":"PMC_20431954","title":"Functional characterization of the novel intronic nucleotide change c.288+9C>T within the BCKDHA gene: understanding a variant presentation of maple syrup urine disease.","date":"2010","source":"Journal of inherited metabolic disease","url":"https://pubmed.ncbi.nlm.nih.gov/20431954","citation_count":5,"is_preprint":false},{"pmid":"7558443","id":"PMC_7558443","title":"Malignant transformation of human fibroblast strain MSU-1.1 by v-fes requires an additional genetic change.","date":"1995","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/7558443","citation_count":5,"is_preprint":false},{"pmid":"37339805","id":"PMC_37339805","title":"Clec12a inhibits MSU-induced immune activation through lipid raft expulsion.","date":"2023","source":"Life science alliance","url":"https://pubmed.ncbi.nlm.nih.gov/37339805","citation_count":4,"is_preprint":false},{"pmid":"38828789","id":"PMC_38828789","title":"The alleviatory effects of koumine on MSU-induced gouty arthritis via the TLR4/NF-κB/NLRP3 pathway.","date":"2024","source":"Basic & clinical pharmacology & toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/38828789","citation_count":4,"is_preprint":false},{"pmid":"19240989","id":"PMC_19240989","title":"Prenatal diagnosis of a novel mutation, c.529C>T (p.Q177X), in the BCKDHA gene in a family with maple syrup urine disease.","date":"2009","source":"Journal of inherited metabolic disease","url":"https://pubmed.ncbi.nlm.nih.gov/19240989","citation_count":4,"is_preprint":false},{"pmid":"40657393","id":"PMC_40657393","title":"IL1A regulates MSU-induced apoptosis and inflammatory response through TLR4/MyD88/NF-κB signaling pathway.","date":"2025","source":"International journal of medical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/40657393","citation_count":3,"is_preprint":false},{"pmid":"39672007","id":"PMC_39672007","title":"Dephosphorylation of branched-chain α-keto acid dehydrogenase E1α (BCKDHA) promotes branched-chain amino acid catabolism and renders cancer cells resistant to X-rays by mitigating DNA damage.","date":"2024","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/39672007","citation_count":3,"is_preprint":false},{"pmid":"19911241","id":"PMC_19911241","title":"The Trichoplusia ni cell line MSU-TnT4 does not harbor a latent nodavirus.","date":"2010","source":"In vitro cellular & developmental biology. Animal","url":"https://pubmed.ncbi.nlm.nih.gov/19911241","citation_count":3,"is_preprint":false},{"pmid":"10694918","id":"PMC_10694918","title":"A nonsense mutation (R242X) in the branched-chain alpha-keto acid dehydrogenase E1alpha subunit gene (BCKDHA) as a cause of maple syrup urine disease. Mutations in brief no. 160. Online.","date":"1998","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/10694918","citation_count":3,"is_preprint":false},{"pmid":"39983819","id":"PMC_39983819","title":"A novel zinc ferrite nanoparticle protects against MSU-induced gout arthritis via Nrf2/NF-κB/NLRP3 pathway.","date":"2025","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/39983819","citation_count":3,"is_preprint":false},{"pmid":"38863059","id":"PMC_38863059","title":"The integrin CD11b inhibits MSU-induced NLRP3 inflammasome activation in macrophages and protects mice against MSU-induced joint inflammation.","date":"2024","source":"Arthritis research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/38863059","citation_count":2,"is_preprint":false},{"pmid":"33607070","id":"PMC_33607070","title":"Identification of the first Alu-mediated gross deletion involving the BCKDHA gene in a compound heterozygous patient with maple syrup urine disease.","date":"2021","source":"Clinica chimica acta; international journal of clinical chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/33607070","citation_count":2,"is_preprint":false},{"pmid":"37715329","id":"PMC_37715329","title":"Highly expressed long non-coding RNA SNHG14 activated MSU-induced inflammatory response in acute gout arthritis through targeting miR-223-3p.","date":"2023","source":"International journal of rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/37715329","citation_count":2,"is_preprint":false},{"pmid":"36341163","id":"PMC_36341163","title":"Maple syrup urine disease due to a paracentric inversion of chr 19 that disrupts BCKDHA: A case report.","date":"2022","source":"JIMD reports","url":"https://pubmed.ncbi.nlm.nih.gov/36341163","citation_count":2,"is_preprint":false},{"pmid":"34883003","id":"PMC_34883003","title":"Three novel mutations of the BCKDHA, BCKDHB and DBT genes in Chinese children with maple syrup urine disease.","date":"2021","source":"Journal of pediatric endocrinology & metabolism : JPEM","url":"https://pubmed.ncbi.nlm.nih.gov/34883003","citation_count":1,"is_preprint":false},{"pmid":"40584622","id":"PMC_40584622","title":"AduCPI2 alleviates MSU-induced acute gouty arthritis in mice by inhibiting cathepsin S and the C5a-C5aR1 axis.","date":"2025","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/40584622","citation_count":1,"is_preprint":false},{"pmid":"41444608","id":"PMC_41444608","title":"PRSS55 regulates BCAA metabolism and interacts with BCKDK and BCKDHA in mouse testes and sperm.","date":"2025","source":"Cell & bioscience","url":"https://pubmed.ncbi.nlm.nih.gov/41444608","citation_count":0,"is_preprint":false},{"pmid":"40846988","id":"PMC_40846988","title":"Mitochondrial calcium uniporter promotes MSU crystal-induced inflammation through inducing mitochondrial Ca2+ overload and ubiquitination of SIRT5 protein.","date":"2025","source":"Arthritis research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/40846988","citation_count":0,"is_preprint":false},{"pmid":"40563570","id":"PMC_40563570","title":"The RXR Agonist MSU-42011 Reduces Tumor Burden in a Murine Preclinical NF1-Deficient Model.","date":"2025","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/40563570","citation_count":0,"is_preprint":false},{"pmid":"42136029","id":"PMC_42136029","title":"Systemic dual-gene therapy reverses biochemical intoxication in the central metabolic compartment of Bckdha-/- mice.","date":"2026","source":"Molecular therapy : the journal of the American Society of Gene Therapy","url":"https://pubmed.ncbi.nlm.nih.gov/42136029","citation_count":0,"is_preprint":false},{"pmid":"42110546","id":"PMC_42110546","title":"Pentagalloyl glucose suppresses MSU crystal-induced gout inflammation and arachidonic acid production in vitro and in vivo.","date":"2026","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/42110546","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":55988,"output_tokens":4819,"usd":0.120124,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":12658,"output_tokens":4774,"usd":0.09132,"stage2_stop_reason":"end_turn"},"total_usd":0.211444,"stage1_batch_id":"msgbatch_0179Z2pxRYBsXi2xADneafRw","stage2_batch_id":"msgbatch_01LaY9ZaVdgjWArcZo9eqQE5","note":"batch pricing = 50% of standard"},"stage1_raw":"Looking through the corpus, I need to identify papers about the canonical BCKDHA protein (E1α subunit of branched-chain α-ketoacid dehydrogenase complex). Most papers in this corpus are about MSU (monosodium urate) crystals in gout — these use \"MSU\" as an abbreviation for monosodium urate, not the BCKDHA alias. I need to carefully separate:\n\n1. Papers about BCKDHA (the metabolic enzyme) — PMIDs: 8463340, 30228974, 26453840, 28417071, 19456321, 21844576, 22145486, 19085071, 20431954, 10694918, 34876693, 37377173, 39389936, 39672007, 40009698, 42136029, 41444608, 33607070, 36341163, 34883003, 29306928, 2805821\n\n2. Papers about MSU crystals/gout — NOT about BCKDHA protein — should be excluded.\n\n3. Papers about MSU cell lines (human fibroblast strain) — not about BCKDHA.\n\nLet me now extract mechanistic discoveries from the BCKDHA papers:\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1989,\n      \"finding\": \"The BCKDHA gene encoding the E1α subunit of branched-chain keto acid dehydrogenase was mapped to human chromosome region 19q13.1–q13.2 by in situ hybridization with 3H-labeled cDNA.\",\n      \"method\": \"Chromosomal in situ hybridization (cytogenetics)\",\n      \"journal\": \"Cytogenetics and cell genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct in situ hybridization localization experiment, single lab, single method\",\n      \"pmids\": [\"2805821\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"The human BCKDHA gene contains 9 exons spanning at least 55 kb; exon 1 is 135 bp with multiple transcription initiation sites at +1, +18, and +22; the promoter lacks a canonical TATA box but contains Sp1, CAAT-like, AP-2, glucocorticoid-responsive element, and cAMP-responsive element sequences. The region for high-level transcription in hepatoma (Hep-G2) cells lies between –320 and –115, with inhibitory elements upstream of –320, while in CHO cells the high-level region extends to –909 to –115, indicating cell-type-specific promoter regulation.\",\n      \"method\": \"Genomic library cloning, sequencing, deletion constructs with luciferase reporter assay in Hep-G2 and CHO cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct functional promoter dissection with deletion constructs and reporter assay, two cell lines, single lab\",\n      \"pmids\": [\"8463340\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"A C-to-T transition in exon 7 of BCKDHA produces a nonsense mutation (R242X) that abolishes branched-chain α-ketoacid dehydrogenase activity, as confirmed in cultured amniocytes with absent enzyme activity from a consanguineous pedigree with MSUD.\",\n      \"method\": \"PCR amplification and mutation analysis of BCKDHA exon 7 in amniocytes with enzyme activity assay\",\n      \"journal\": \"Human mutation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — enzymatic activity correlated with specific mutation, single case/pedigree, single lab\",\n      \"pmids\": [\"10694918\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"A large deletion of ~13.8 kb in BCKDHA encompassing exons 2–4 (from intron 1 to intron 4) causes MSUD; the deletion junction contains a short CGGG motif present in both introns, supporting non-homologous recombination as the causative mechanism.\",\n      \"method\": \"Long-range PCR and sequencing to characterize deletion breakpoints in a MSUD patient\",\n      \"journal\": \"Journal of inherited metabolic disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — direct molecular characterization of deletion breakpoints, mechanistic inference about non-homologous recombination, single case\",\n      \"pmids\": [\"19085071\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"The c.117delC-α (p.R40GfsX23) mutation in BCKDHA is a founder mutation responsible for high MSUD incidence among Portuguese Gypsies, as demonstrated by haplotype analysis with four flanking microsatellite markers; the genomic region around this mutation is a mutational hotspot since it was also found recurrently in distinct population groups.\",\n      \"method\": \"Microsatellite haplotyping and population genetics analysis flanking the BCKDHA gene\",\n      \"journal\": \"Annals of human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct haplotype analysis linking mutation to founder effect, replicated in two population groups, single lab\",\n      \"pmids\": [\"19456321\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The intronic mutation c.288+9C>T in BCKDHA creates a cryptic splice site, causing insertion of a 7-bp fragment from intron 2 into the mRNA with a premature stop codon; this aberrant transcript is subject to nonsense-mediated mRNA decay (NMD), as demonstrated by emetine rescue and minigene splicing assays. A low level of normal mRNA is also produced from this allele, correlating with the milder variant MSUD phenotype observed in the patient (compound heterozygous with the severe p.Gly249Ser allele).\",\n      \"method\": \"Direct mRNA analysis from patient cells, emetine rescue experiment, minigene splicing assay\",\n      \"journal\": \"Journal of inherited metabolic disease\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — minigene reconstitution, patient mRNA analysis, and emetine rescue provide orthogonal mechanistic evidence; single lab\",\n      \"pmids\": [\"20431954\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Two novel missense mutations in BCKDHA — p.L103P (in the helical region) and p.R265P (in the core domain near the cofactor/manganese-binding site) — were identified in a Chinese MSUD patient; structural modeling indicated p.L103P disrupts hydrophobic cores and shortens the helix, while p.R265P affects the cofactor binding site by altering manganese ion coordination.\",\n      \"method\": \"Sanger sequencing of BCKDHA, protein structural modeling with PyMOL\",\n      \"journal\": \"Journal of pediatric endocrinology & metabolism : JPEM\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 / Weak — structural inference is computational only (PyMOL modeling), no in vitro functional validation\",\n      \"pmids\": [\"22145486\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"BIX01294 (a G9a inhibitor) transcriptionally downregulates BCKDHA expression in EGFR-mutant NSCLC cells through inhibition of KDM3A (a Jumonji histone demethylase) rather than G9a; KDM3A epigenetically regulates BCKDHA expression by binding to the BCKDHA gene promoter. BCKDHA downregulation reduces mitochondrial metabolic function and TCA cycle fueling, leading to decreased cellular energy levels, reduced EGFR protein levels, and apoptosis specifically in EGFR-mutant cells.\",\n      \"method\": \"BIX01294 treatment, BCKDHA knockdown, chromatin binding assay (KDM3A at BCKDHA promoter), mitochondrial metabolic assays, apoptosis assays in NSCLC cells\",\n      \"journal\": \"Experimental & molecular medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (promoter binding, genetic knockdown, metabolic assays, apoptosis), single lab\",\n      \"pmids\": [\"34876693\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Alu-element-mediated gross deletion involving exons 1–9 of BCKDHA causes MSUD in a compound heterozygous patient; the deletion breakpoints were mapped within microhomologous sequences in two Alu elements, establishing Alu-mediated recombination as the causative mechanism — the first report of Alu-mediated rearrangement at BCKDHA.\",\n      \"method\": \"Targeted capture sequencing, real-time PCR CNV analysis, whole genome sequencing, long-range PCR, Sanger sequencing to map deletion breakpoints\",\n      \"journal\": \"Clinica chimica acta; international journal of clinical chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — multiple sequencing methods converging on breakpoint mapping, mechanistic inference from Alu microhomology, single case/lab\",\n      \"pmids\": [\"33607070\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"A paracentric inversion of chromosome 19 that disrupts intron 1 of BCKDHA causes classic MSUD in compound heterozygosity with a missense variant (p.Ala253Thr); the inversion was identified by whole-genome sequencing and validated by FISH, and the breakpoint junction sequence was characterized, providing mechanistic insight into structural rearrangement at this locus.\",\n      \"method\": \"Whole-genome sequencing, FISH, junction-specific PCR, Sanger sequencing\",\n      \"journal\": \"JIMD reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — multiple orthogonal methods for structural characterization, single case, single lab\",\n      \"pmids\": [\"36341163\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"BCKDHA promotes melanoma cell proliferation, invasion, migration in vitro and tumor growth in vivo; mechanistically, BCKDHA upregulates the expression of lipogenic enzymes FASN and ATP-citrate lyase (ACLY), which mediate its oncogenic role, as demonstrated by RNA sequencing and functional rescue experiments.\",\n      \"method\": \"In vitro cell biology (knockdown/overexpression), in vivo xenograft model, RNA sequencing, immunohistochemistry, bioinformatics\",\n      \"journal\": \"Experimental dermatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional knockdown/overexpression with in vivo validation, RNA-seq mechanistic follow-up, single lab\",\n      \"pmids\": [\"37377173\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"BCKDK regulates hepatic gluconeogenesis independently of BCKDHA: liver-specific BCKDK knockout inhibits hepatic glucose production and gluconeogenic enzyme expression, whereas liver-specific BCKDHA knockout has no effect on gluconeogenesis. Mechanistically, BT2-mediated BCKDK inhibition attenuates interaction of CREB with CREB-binding protein and promotes FOXO1 ubiquitination and degradation, establishing a BCKDHA-independent pathway for BCKDK in glucose metabolism.\",\n      \"method\": \"Liver-specific knockout mice (BCKDK and BCKDHA), primary hepatocyte experiments, BT2 inhibitor treatment, BCKDK overexpression, co-immunoprecipitation (CREB–CBP interaction), ubiquitination assay for FOXO1\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — genetic KO of both BCKDK and BCKDHA in parallel, primary hepatocyte mechanistic experiments, Co-IP and ubiquitination assays, multiple orthogonal methods in single study clearly distinguishing BCKDHA-dependent vs. -independent roles\",\n      \"pmids\": [\"39389936\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Dephosphorylation (activation) of BCKDHA promotes BCAA catabolism and renders cancer cells resistant to X-irradiation by maintaining ATP levels and mitigating DNA damage (mitotic catastrophe and residual double-strand breaks). X-irradiation dose-dependently dephosphorylates BCKDHA, suggesting BCKDH complex activation; BCKDHA knockdown increases radiosensitivity.\",\n      \"method\": \"X-irradiation of cancer cells, BCKDHA phosphorylation state analysis, BCKDHA knockdown, measurement of ATP levels, mitotic catastrophe, and residual DSBs\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic knockdown with multiple phenotypic readouts (radiosensitivity, ATP, DSBs), mechanistic link through phosphorylation state, single lab\",\n      \"pmids\": [\"39672007\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"PRSS55 (testis-specific serine protease) physically interacts with both BCKDK and BCKDHA in mouse testes and sperm, as validated by LC-MS/MS proteomics and Co-IP; loss of PRSS55 leads to accumulation of BCAAs (valine, leucine, isoleucine) and impaired mitochondrial function/ATP production in sperm, establishing PRSS55 as a regulator of BCAA catabolism upstream of the BCKDK–BCKDHA axis.\",\n      \"method\": \"Prss55 knockout mice, proteomics (LC-MS/MS), metabolomics, Co-IP, immunofluorescence, immunoblotting, mitochondrial function assays (ATP, membrane potential)\",\n      \"journal\": \"Cell & bioscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — Co-IP interaction validated by MS, KO mouse with metabolomics and mitochondrial functional readouts, multiple orthogonal methods in single study\",\n      \"pmids\": [\"41444608\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Dual-gene AAV9 vector (rAAV9.hA-BiP-hB) delivering codon-optimized BCKDHA and BCKDHB restores BCKDH holoenzyme activity in BCKDHA-knockout HEK293T cells and rescues perinatal lethality, normalizes growth, and stabilizes MSUD biomarkers in both Bckdha and Bckdhb mouse models and a newborn calf with BCKDHA c.248C>T. Coordinated BCKDHA and BCKDHB coexpression is required for holoenzyme activity, demonstrating that both E1α and E1β subunits are necessary for functional BCKDH complex assembly.\",\n      \"method\": \"AAV9 gene delivery, BCKDH holoenzyme activity assay in HEK293T cells, Bckdha/Bckdhb knockout mouse models, natural bovine MSUD model, biochemical and growth outcome measures\",\n      \"journal\": \"Science translational medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — enzymatic reconstitution in cell line plus rescue in two KO mouse models and a natural disease animal model; multiple independent model systems validate holoenzyme assembly requirement\",\n      \"pmids\": [\"40009698\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"In Bckdha−/− mice, BCKDH deficiency causes a 9-fold elevation of brain 2-ketoisocaproate, cerebral depletion of glutamate and glutamine, and disruption of TCA cycle and ketone body metabolism; these arise from reversal of branched-chain aminotransferase 2 (BCAT2) flux and destabilization of glutamate–2-ketoglutarate mass balance. Systemic AAV9 dual-gene therapy (A-BiP-B encoding BCKDHA and BCKDHB) partially restored cerebral BCKDHA mRNA and brought brain neurochemical endpoints within wild-type range, demonstrating that BCKDHA is required for central nervous system metabolic homeostasis beyond peripheral amino acid control.\",\n      \"method\": \"Bckdha−/− mouse model, paired serum-brain metabolomics, AAV9 gene therapy rescue, RT-qPCR for BCKDHA mRNA in brain\",\n      \"journal\": \"Molecular therapy : the journal of the American Society of Gene Therapy\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — KO mouse with comprehensive paired metabolomics and gene therapy rescue; mechanistic pathway (BCAT2 flux reversal, glutamate depletion) defined by metabolomic data in single rigorous study\",\n      \"pmids\": [\"42136029\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"BCKDHA encodes the E1α subunit of the mitochondrial branched-chain α-ketoacid dehydrogenase (BCKDH) complex; it is phosphorylated (inactivated) by BCKDK and must be co-expressed with E1β (BCKDHB) for holoenzyme assembly and decarboxylation of ketoacid derivatives of leucine, isoleucine, and valine; its dephosphorylation/activation channels BCAA-derived carbon into the TCA cycle, maintaining cellular ATP levels and neurochemical homeostasis; BCKDHA expression is epigenetically regulated at its promoter by the histone demethylase KDM3A; PRSS55 interacts physically with the BCKDK–BCKDHA axis to regulate BCAA catabolism in sperm; and in cancer contexts BCKDHA supports tumor progression by promoting lipogenesis (via FASN/ACLY) and radiation resistance via ATP-dependent DNA damage mitigation.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"BCKDHA encodes the E1\\u03b1 subunit of the mitochondrial branched-chain \\u03b1-ketoacid dehydrogenase (BCKDH) complex, the committed enzymatic step that decarboxylates the ketoacid derivatives of leucine, isoleucine, and valine and channels branched-chain amino acid (BCAA)-derived carbon into the TCA cycle [#14, #15]. Functional holoenzyme assembly requires coordinated coexpression of E1\\u03b1 (BCKDHA) and E1\\u03b2 (BCKDHB): codon-optimized dual-gene delivery of both subunits is necessary and sufficient to reconstitute BCKDH activity in BCKDHA-null cells and to rescue perinatal lethality and MSUD biomarkers in animal models [#14]. Loss of BCKDHA function causes maple syrup urine disease (MSUD), arising from diverse lesions including nonsense, missense, and splice mutations as well as large structural rearrangements at the 19q13 locus [#2, #5, #8, #9]. Enzyme activity is governed by the phosphorylation state of the E1\\u03b1 subunit; dephosphorylation activates the complex, and in cancer this activation sustains BCAA catabolism, ATP levels, and radiation resistance, while BCKDHA knockdown increases radiosensitivity [#12]. BCKDHA transcription is epigenetically controlled through KDM3A binding at its promoter, and its loss reduces mitochondrial TCA-cycle fueling and drives apoptosis in EGFR-mutant tumor cells [#7]; in melanoma BCKDHA promotes proliferation and invasion by upregulating the lipogenic enzymes FASN and ACLY [#10]. Beyond peripheral amino acid handling, BCKDHA is required for central nervous system metabolic homeostasis, since its loss elevates brain 2-ketoisocaproate and depletes glutamate/glutamine via reversal of BCAT2 flux [#15]. The E1\\u03b1 subunit also lies downstream of regulatory inputs from PRSS55 in sperm and is functionally distinct from BCKDK's BCKDHA-independent control of hepatic gluconeogenesis [#11, #13].\",\n  \"teleology\": [\n    {\n      \"year\": 1989,\n      \"claim\": \"Establishing the chromosomal location of BCKDHA was the first step in defining it as a discrete genetic locus for the E1\\u03b1 subunit and a candidate for inherited metabolic disease.\",\n      \"evidence\": \"In situ hybridization with 3H-labeled cDNA mapping to 19q13.1\\u2013q13.2\",\n      \"pmids\": [\"2805821\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No functional or expression data\", \"Did not define gene structure or regulation\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Dissecting the gene's exon structure and promoter revealed how BCKDHA transcription is controlled, including TATA-less initiation and cell-type-specific regulatory elements.\",\n      \"evidence\": \"Genomic cloning, sequencing, and deletion-reporter luciferase assays in Hep-G2 and CHO cells\",\n      \"pmids\": [\"8463340\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Trans-acting factors binding the promoter not identified\", \"In vivo relevance of cell-type differences unresolved\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Linking a specific nonsense mutation to absent enzyme activity established BCKDHA loss-of-function as causative for MSUD.\",\n      \"evidence\": \"Mutation analysis and enzyme assay in amniocytes from a consanguineous MSUD pedigree (R242X)\",\n      \"pmids\": [\"10694918\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single pedigree\", \"No biochemical reconstitution of the mutant protein\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Characterizing a large intragenic deletion and its breakpoint motif extended the MSUD mutational spectrum to structural rearrangements driven by non-homologous recombination.\",\n      \"evidence\": \"Long-range PCR and breakpoint sequencing in an MSUD patient (exons 2\\u20134 deletion)\",\n      \"pmids\": [\"19085071\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single case\", \"Recombination mechanism inferred from motif rather than directly demonstrated\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Identifying a founder mutation and recurrent hotspot explained population-level MSUD incidence and the recurrence of certain BCKDHA lesions.\",\n      \"evidence\": \"Microsatellite haplotyping flanking BCKDHA in Portuguese Gypsy and other populations (c.117delC)\",\n      \"pmids\": [\"19456321\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No functional characterization of the frameshift allele\", \"Hotspot mechanism not molecularly defined\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Demonstrating that an intronic variant creates a cryptic splice site triggering NMD, with residual normal transcript, explained genotype\\u2013phenotype correlation for milder variant MSUD.\",\n      \"evidence\": \"Patient mRNA analysis, emetine rescue, and minigene splicing assay (c.288+9C>T)\",\n      \"pmids\": [\"20431954\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Quantitative threshold of residual activity for phenotype not defined\", \"Single patient context\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Structural modeling of missense mutations proposed how residue changes near the helical and cofactor/manganese-binding regions impair E1\\u03b1.\",\n      \"evidence\": \"Sanger sequencing and PyMOL structural modeling of p.L103P and p.R265P in a Chinese MSUD patient\",\n      \"pmids\": [\"22145486\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Computational modeling only, no in vitro functional validation\", \"Effect on holoenzyme assembly untested\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Identifying KDM3A as an epigenetic regulator of BCKDHA established transcriptional control of the gene and linked its expression to mitochondrial energy supply in EGFR-mutant cancer.\",\n      \"evidence\": \"BIX01294 treatment, BCKDHA knockdown, KDM3A promoter chromatin binding, and metabolic/apoptosis assays in NSCLC cells\",\n      \"pmids\": [\"34876693\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab and cancer context\", \"Direct KDM3A demethylase activity at the locus not biochemically resolved\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Mapping an Alu-mediated gross deletion of the entire gene further broadened the structural mutation landscape underlying MSUD.\",\n      \"evidence\": \"Targeted capture, WGS, CNV PCR, and breakpoint sequencing in a compound heterozygous MSUD patient (exons 1\\u20139 deletion)\",\n      \"pmids\": [\"33607070\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single case\", \"Recombination mechanism inferred from microhomology\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Characterizing a paracentric inversion disrupting intron 1 demonstrated that non-deletional structural rearrangements can also cause classic MSUD.\",\n      \"evidence\": \"WGS, FISH, and junction-specific sequencing in a compound heterozygous patient\",\n      \"pmids\": [\"36341163\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single case\", \"Transcriptional consequence of the inversion not directly assayed\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Defining a lipogenic axis showed that BCKDHA can act as a pro-tumorigenic gene by upregulating FASN and ACLY, extending its role beyond catabolic housekeeping.\",\n      \"evidence\": \"Knockdown/overexpression, xenografts, RNA-seq, and rescue experiments in melanoma\",\n      \"pmids\": [\"37377173\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism linking BCKDHA to FASN/ACLY induction undefined\", \"Single tumor type and lab\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Parallel liver-specific knockouts dissociated BCKDK's control of gluconeogenesis from BCKDHA, showing BCKDK has a BCKDHA-independent role in glucose metabolism.\",\n      \"evidence\": \"Liver-specific BCKDK and BCKDHA knockout mice, BT2 treatment, CREB\\u2013CBP Co-IP, and FOXO1 ubiquitination assays\",\n      \"pmids\": [\"39389936\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Establishes what BCKDHA does NOT do, not a new BCKDHA function\", \"Tissue specificity of the dissociation in non-hepatic contexts unknown\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Linking the phosphorylation state of E1\\u03b1 to radiation resistance showed that BCKDH activation sustains ATP and mitigates DNA damage in cancer cells.\",\n      \"evidence\": \"X-irradiation, BCKDHA phosphorylation analysis, knockdown, and ATP/DSB/mitotic-catastrophe readouts in cancer cells\",\n      \"pmids\": [\"39672007\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Phosphatase mediating dephosphorylation not identified\", \"Mechanism connecting ATP to DSB repair not resolved\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Identifying PRSS55 as a physical partner of the BCKDK\\u2013BCKDHA axis placed E1\\u03b1 within a tissue-specific regulatory complex controlling sperm BCAA catabolism and mitochondrial energetics.\",\n      \"evidence\": \"Prss55 knockout mice, LC-MS/MS proteomics, Co-IP, metabolomics, and mitochondrial function assays in testes/sperm\",\n      \"pmids\": [\"41444608\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular consequence of PRSS55 binding on BCKDHA activity unresolved\", \"Protease substrate relationship not defined\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Demonstrating that coordinated E1\\u03b1/E1\\u03b2 coexpression reconstitutes holoenzyme activity and rescues disease across models established the obligate two-subunit requirement and a gene therapy strategy.\",\n      \"evidence\": \"Dual-gene AAV9 delivery, holoenzyme activity assay in BCKDHA-KO HEK293T, Bckdha/Bckdhb KO mice, and a natural bovine MSUD model\",\n      \"pmids\": [\"40009698\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Long-term durability of rescue not addressed\", \"Stoichiometry and assembly intermediates not structurally resolved\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Paired serum-brain metabolomics in knockout mice defined a CNS-specific consequence of BCKDHA loss\\u2014BCAT2 flux reversal and glutamate/glutamine depletion\\u2014and showed gene therapy normalizes brain neurochemistry.\",\n      \"evidence\": \"Bckdha\\u2212/\\u2212 mice, paired metabolomics, AAV9 dual-gene rescue, and brain BCKDHA RT-qPCR\",\n      \"pmids\": [\"42136029\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cell-type resolution of brain metabolic changes lacking\", \"Causal link from neurochemical shifts to neurological phenotype not fully traced\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the phosphorylation/dephosphorylation cycle of E1\\u03b1 is integrated with upstream regulators (PRSS55, KDM3A) and tissue-specific signaling to tune BCKDH activity dynamically remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Phosphatase activating BCKDHA in cancer not identified\", \"Structural basis of E1\\u03b1/E1\\u03b2 holoenzyme assembly and cofactor coordination not experimentally solved\", \"Mechanism linking BCKDHA to lipogenic enzyme induction undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016829\", \"supporting_discovery_ids\": [2, 14]},\n      {\"term_id\": \"GO:0016491\", \"supporting_discovery_ids\": [14, 15]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [7, 13]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [14, 15]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [2, 14]}\n    ],\n    \"complexes\": [\"branched-chain \\u03b1-ketoacid dehydrogenase (BCKDH) complex\"],\n    \"partners\": [\"BCKDHB\", \"BCKDK\", \"PRSS55\", \"KDM3A\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}